We also could identify non-redundant role of the cell surface lactate receptor GPR81 and the monocarboxylate transporters in mediating the effects of lactate on pDCs, in terms of both IFNα induction as well as ability to expand regulatory T cells, revealing new therapeutic targets for potentiating anti-cancer immune responses. The gene discussed is IFNA1; the disease is cancer.